Endo has expanded the recall of Clonazepam Orally Disintegrating Tablets (ODT) to include additional lots that may ...
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its ...
After a labeling mix-up prompted a recall of a popular panic disorder drug this summer, Endo’s U.S. subsidiary is widening the scope of its product pull. | Endo USA is expanding its previous recall of ...